We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1B
AUM Growth
+$81M
Cap. Flow
+$45.8M
Cap. Flow %
4.57%
Top 10 Hldgs %
62.52%
Holding
4,698
New
814
Increased
790
Reduced
1,480
Closed
1,566

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$13.3M
2
MSFT icon
Microsoft
MSFT
+$11.7M
3
XOM icon
ExxonMobil
XOM
+$10.9M
4
BAC icon
Bank of America
BAC
+$8.84M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.82M

Sector Composition

Rank Sector Weight
1 Financials 1.65%
2 Technology 1.48%
3 Materials 1.36%
4 Healthcare 1.28%
5 Industrials 1.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEL
1801
DELISTED
Cellcom Israel, Ltd.
CEL
$10K ﹤0.01%
1,012
-5
-0.5% -$51
GPOR
1802
DELISTED
Gulfport Energy Corp.
GPOR
$10K ﹤0.01%
590
-2,672
-82% -$51.2K
BREW
1803
DELISTED
Craft Brew Alliance, Inc.
BREW
$10K ﹤0.01%
712
-1,049
-60% -$15.6K
ASFI
1804
DELISTED
Asta Funding Inc
ASFI
$10K ﹤0.01%
1,283
+1,279
+31,975% +$12.1K
CORV
1805
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$10K ﹤0.01%
2,593
+1,562
+152% +$4.61K
CBPX
1806
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
$10K ﹤0.01%
394
+57
+17% +$1.38K
WAIR
1807
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
$10K ﹤0.01%
+900
New +$11.9K
NVLN
1808
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$10K ﹤0.01%
900
+472
+110% +$4.82K
PETX
1809
DELISTED
Aratana Therapeutics, Inc.
PETX
$10K ﹤0.01%
1,971
-2,627
-57% -$17.7K
SFS
1810
DELISTED
Smart & Final Stores, Inc.
SFS
$10K ﹤0.01%
800
-7,205
-90% -$98.4K
CXRX
1811
DELISTED
Concordia International Corp. Common Stock
CXRX
$10K ﹤0.01%
4,771
-8,600
-64% -$18.5K
DHXM
1812
DELISTED
DHX Media Ltd. Common Voting and Variable Voting Shares
DHXM
$10K ﹤0.01%
1,900
+900
+90% +$4.14K
APLP
1813
DELISTED
Archrock Partners, L.P. Common Units representing Limited Partner Interests
APLP
$10K ﹤0.01%
+590
New +$10.3K
NTL
1814
DELISTED
Nortel Invesora 1/20 Ser B Shr
NTL
$10K ﹤0.01%
+400
New +$10K
VTTI
1815
DELISTED
VTTI Energy Partners LP
VTTI
$10K ﹤0.01%
533
+453
+566% +$8.31K
CCN
1816
DELISTED
CardConnect Corp.
CCN
$10K ﹤0.01%
757
-592
-44% -$8.14K
UAM
1817
DELISTED
Universal American Corp
UAM
$10K ﹤0.01%
1,000
-1,560
-61% -$15.5K
XXIA
1818
DELISTED
Ixia
XXIA
$10K ﹤0.01%
500
-3,266
-87% -$61.3K
CBMX
1819
DELISTED
CombiMatrix Corporation
CBMX
$10K ﹤0.01%
+1,900
New +$7.7K
CAVM
1820
DELISTED
Cavium, Inc.
CAVM
$10K ﹤0.01%
136
-3,641
-96% -$244K
UBOH
1821
DELISTED
United Bancshares Inc/OH
UBOH
$10K ﹤0.01%
+451
New +$9.86K
DZK
1822
DELISTED
Direxion Daily Developed Markets Bull 3x Shares
DZK
$10K ﹤0.01%
+179
New +$9.22K
NMRX
1823
DELISTED
Numerex Corp
NMRX
$10K ﹤0.01%
2,191
+339
+18% +$1.92K
ADSK icon
1824
Autodesk
ADSK
$50.1B
$9K ﹤0.01%
100
-8,803
-99% -$737K
AFL icon
1825
Aflac
AFL
$63.5B
$9K ﹤0.01%
254
-25,262
-99% -$895K

Similar funds

Tower Research Capital (TRC)'s Q1 2017 Portfolio in Review

As of Q1 2017, Tower Research Capital (TRC) held 4,698 positions worth $1B, up 8.8% from $921M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Tower Research Capital (TRC) deployed $45.8M of net new capital in Q1 2017, opening 814 new positions and adding to 790 existing holdings. Its largest new stake was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.

By sector, the portfolio is most concentrated in Financials at 1.7% of assets, down from 14% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Apple, an estimated $13.3M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2017 buy was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $213M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2017 reduction was Apple, cutting an estimated $13.3M.
  • Tower Research Capital (TRC) fully exited Berkshire Hathaway Class B in Q1 2017, selling an estimated $8.82M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 63% of its $1B portfolio in Q1 2017.
  • Tower Research Capital (TRC) opened 814 new positions and closed 1,566 in Q1 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 8.8% quarter-over-quarter to $1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2017, filed 19 May 2017.